Document 3038 DOCN M94A3038 TI Correlation of selected CD8 lymphocyte activation markers with quantitative cellular viremia in asymptomatic HIV infected individuals. DT 9412 AU Levacher-Clergeot M; Bouscarat F; Dazza MC; Sinet M; Strauss K; Girard PM; Rozenbaum W; Coulaud JP; Pocidalo JJ; INSERM U13, Paris, France. SO Int Conf AIDS. 1994 Aug 7-12;10(1):168 (abstract no. PB0100). Unique Identifier : AIDSLINE ICA10/94369537 AB OBJECTIVE: Multi-colour flow cytometry has demonstrated significant alterations within the CD8 subsets co-expressing activation markers in HIV infection. Our study focuses on the correlation of these CD8 subsets with viral load in asymptomatic HIV infected patients with no marked CD4 lymphocyte depletion. PATIENTS AND METHODS: Blood samples were obtained from 49 HIV infected patients and 23 HIV- individuals. All HIV infected patients were asymptomatic, were accrued within two years of diagnosis (14.4 +/- 1.3 months), and had a CD4 cell count above 400 cells/microliters (788 +/- 43). An extensive panel of three colour reagent combinations was assessed by flow cytometry. Levels of HIV viremia were measured both in PBMC's and in plasma using end point dilution cultures. RESULTS: Thirty-nine patients had a positive cellular viremia (0.5 to 5315 TCID50/10(6) cells), while only 5 had a positive plasma viremia. Mean CD8% was 50.9 +/- 1.5 in patients versus 33.3 +/- 1.3 in controls. Bright CD8 accounted for the expansion of the CD8 cells. All subset results are in proportion of the bright CD8 population. Table: mean +/- SE of relevant values and respective correlation coefficient-r versus cellular viremia. TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS: We confirm and extend the finding of increased specific CD8 subsets to asymptomatic HIV infected individuals with no marked CD4 depletion. Among these subsets, %CD38+CD45RO+ and %CD38+CD28- are significantly correlated to cellular viremia. HIV plasmatic RNA quantification is in progress. A longitudinal study will determine if these subsets can be used as a prognostic indicator. DE Antigens, CD28/BLOOD Antigens, CD8/*BLOOD Antigens, Differentiation/BLOOD Flow Cytometry Follow-Up Studies Human HIV/*IMMUNOLOGY HIV Infections/DIAGNOSIS/*IMMUNOLOGY HLA-DR Antigens/BLOOD Leukocyte Count Lymphocyte Transformation/*IMMUNOLOGY Monocytes/IMMUNOLOGY/MICROBIOLOGY T-Lymphocytes, Suppressor-Effector/*IMMUNOLOGY T4 Lymphocytes/IMMUNOLOGY Viremia/DIAGNOSIS/*IMMUNOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).